Comparing Durvalumab, Olaparib, and Cediranib Monotherapy, Combination Therapy, or Chemotherapy in Patients with Platinum-Resistant Ovarian Cancer with Prior Bevacizumab: The Phase Ii Nrg-Gy023 Trial

AuthID
 P-018-PDC
20
Author(s)
Lee J.M.
·
Miller A.
·
Rose P.G.
·
Alhilli M.
·
Washington C.
·
John V.S.
·
Shah C.A.
·
Matsuo K.
·
Siedel J.
·
Hopp E.E.
·
O’shea A.
·
Chan J.K.
·
Bradford L.S.
·
Morse C.B.
·
Nagel C.I.
·
Rodabaugh K.J.
·
Kohn E.C.
·
Moore K.N.
·
Liu J.F.
Document Type
Article
Year published
2025
Published
in Clinical Cancer Research, ISSN: 10780432
Volume: 31, Issue: 12, Pages: 2370-2378 (8)
Indexing
Scopus®
Crossref®
Pubmed®
Google Scholar®
Publication Identifiers
Pubmed: 40192715
Scopus: 2-s2.0-105008776673
Source Identifiers
ISSN: 10780432
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

footer slogan

Useful Links

Get Help

© 2025 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service